Please provide your email address to receive an email when new articles are posted on . Outset Medical, maker of the Tablo hemodialysis machine, reported that the device was added to 30 new hospital ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced that its Tablo® Hemodialysis System has received the first-ever approval from the Centers for Medicare ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Fifty-seven year old dialysis patient Tracey Amadi of central New Jersey is the first person in the world to use Outset Medical’s mobile Tablo Hemodialysis System at ...

Outset Medical got its Tablo all-in-one diabetes dialysis device cleared by FDA in November. Now investors, including existing backers Warburg Pincus and The Vertical Group, are ponying up $59.6 ...

SAN JOSE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Northwest Kidney Centers, the first organization to establish a home hemodialysis program, today announced a collaboration with Outset Medical, Inc ...

SAN JOSE, Calif.--(BUSINESS WIRE)--The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have named Outset Medical’s Tablo Hemodialysis System ® one of ...

Dialysis player Outset Medical attracted a lot of media attention last month when it released an SEC filing for a $60 million equity financing. Now, it's ready to give a much more detailed account of ...

The Tablo System promises to make dialysis easier and more convenient for patients. But there are significant barriers to the technology. By Dawn MacKeen This article is part of Upstart, a series ...

Please provide your email address to receive an email when new articles are posted on . In a press release, the company said the expansion of its leadership “will help strengthen global operations and ...

The home dialysis market is growing. Outset Medical's Tablo system has been deemed a substantial clinical improvement over current home dialysis units. With increasing revenues and a growing backlog, ...

The FDA cleared Outset's Tablo dialysis device for home use. Home dialysis presents an $8.9 billion annual market opportunity for Outset. Reimbursement changes should help boost use of Tablo in home ...

Outset Medical (NASDAQ: OM) seemed to be at an important inflection point in the home dialysis market. The company shipped a record number of its Tablo systems for home patients in the first quarter ...